Author
Listed:
- Gina M. DeNicola
(Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK
Abramson Family Cancer Research Institute, University of Pennsylvania)
- Florian A. Karreth
(Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK
University of Vienna, Dr. Bohrgasse 9, 1030 Vienna, Austria)
- Timothy J. Humpton
(Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK)
- Aarthi Gopinathan
(Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK
Abramson Family Cancer Research Institute, University of Pennsylvania)
- Cong Wei
(Center for Cancer Pharmacology, University of Pennsylvania)
- Kristopher Frese
(Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK)
- Dipti Mangal
(Center for Cancer Pharmacology, University of Pennsylvania)
- Kenneth H. Yu
(Center for Cancer Pharmacology, University of Pennsylvania)
- Charles J. Yeo
(Jefferson Medical College)
- Eric S. Calhoun
(Alma College)
- Francesca Scrimieri
(The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions)
- Jordan M. Winter
(The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions)
- Ralph H. Hruban
(The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions
The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions)
- Christine Iacobuzio-Donahue
(The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions
The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions)
- Scott E. Kern
(The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions
The Sol Goldman Pancreatic Cancer Research Center, the Johns Hopkins Medical Institutions)
- Ian A. Blair
(Center for Cancer Pharmacology, University of Pennsylvania)
- David A. Tuveson
(Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK)
Abstract
Radical role reversal Reactive oxygen species (ROS), such as free radicals, are mutagenic and might therefore be expected to promote tumorigenesis. However, this work shows that expression of the oncogenes Kras, Braf and Myc at endogenous levels in mouse cells in fact reduces ROS levels. Some oncogenes are also shown to induce the transcription factor Nrf2, which acts to detoxify ROS. In line with this finding, deletion of Nrf2 impairs K-Ras-induced pancreatic tumour formation. Modulation of the redox state in cells thus seems to be an important factor in determining tumorigenic potential, and may be a possible target for therapy.
Suggested Citation
Gina M. DeNicola & Florian A. Karreth & Timothy J. Humpton & Aarthi Gopinathan & Cong Wei & Kristopher Frese & Dipti Mangal & Kenneth H. Yu & Charles J. Yeo & Eric S. Calhoun & Francesca Scrimieri & J, 2011.
"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis,"
Nature, Nature, vol. 475(7354), pages 106-109, July.
Handle:
RePEc:nat:nature:v:475:y:2011:i:7354:d:10.1038_nature10189
DOI: 10.1038/nature10189
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Athanasios Valavanidis & Thomais Vlachogianni & Konstantinos Fiotakis & Spyridon Loridas, 2013.
"Pulmonary Oxidative Stress, Inflammation and Cancer: Respirable Particulate Matter, Fibrous Dusts and Ozone as Major Causes of Lung Carcinogenesis through Reactive Oxygen Species Mechanisms,"
IJERPH, MDPI, vol. 10(9), pages 1-22, August.
- Weiqiang Lu & Jiayan Cui & Wanyan Wang & Qian Hu & Yun Xue & Xi Liu & Ting Gong & Yiping Lu & Hui Ma & Xinyu Yang & Bo Feng & Qi Wang & Naixia Zhang & Yechun Xu & Mingyao Liu & Ruth Nussinov & Feixion, 2024.
"PPIA dictates NRF2 stability to promote lung cancer progression,"
Nature Communications, Nature, vol. 15(1), pages 1-20, December.
- Rana Salam & Alexa Saliou & Franck Bielle & Mathilde Bertrand & Christophe Antoniewski & Catherine Carpentier & Agusti Alentorn & Laurent Capelle & Marc Sanson & Emmanuelle Huillard & Léa Bellenger & , 2023.
"Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma,"
Nature Communications, Nature, vol. 14(1), pages 1-21, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:475:y:2011:i:7354:d:10.1038_nature10189. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.